Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union
Pharma giant targets new standards of care
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
KRAS G12C-mutant advanced or metastatic nonsquamous non-small cell lung cancer
Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
Subscribe To Our Newsletter & Stay Updated
